Adaptive Biotechnologies Corporation announced that Tycho Peterson will depart the company as CFO. Kyle Piskel, the company's Principal Accounting Officer, will succeed Peterson as full-time CFO. Piskel served as the company's interim CFO from February to June 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.485 USD | +9.59% | +18.77% | -28.98% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.98% | 469M | |
-25.97% | 10.94B | |
+64.39% | 3.75B | |
-29.02% | 2.27B | |
-10.06% | 2.25B | |
-25.48% | 1.54B | |
+50.00% | 1.18B | |
-2.84% | 754M | |
-11.04% | 529M | |
+14.12% | 340M |
- Stock Market
- Equities
- ADPT Stock
- News Adaptive Biotechnologies Corporation
- Adaptive Biotechnologies Corporation Announces CFO Changes